Keywords: pronova, sees, 11m, kroner, 3rd-qtr, profit, norway
Pronova sees 11M kroner 3rd-qtr profit
Article | 19 November 2007
Norway's Pronova Biopharma, a developer of omega-3 derived drug products, swung into a 30.2 million Norwegian kroner ($5.6 million) third-quarter profit, from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
